OmniComm Systems, Inc. (OTCBB: OMCM), a global provider of eClinical solutions announced that it released TrialOne, a fully integrated, MS , web-based solution designed to automate the Phase I Clinical Trial Process. TrialOne provides all necessary web-based tools used to recruit study volunteers, schedule screening appointments, collect screening data, directly capture real-time data, track sample transfers and address the unique requirements of early phase studies. Within each study, real-time electronic data is captured and validated directly at the subject's bedside or at a subject queuing station. Enhanced workflow technology automates sample processing throughout the lab. TrialOne supports a myriad of directly attached biomedical monitoring devices such as the GE Healthcare DINAMAP® family of vital signs monitors and various ECG devices.

TrialOne enables Phase I Clinics to share data directly with other stakeholders via the internet and provides a flexible ad-hoc reporting tool to help export and report data in various formats including Adobe® PDF, Microsoft® Excel and Word. Further extensibility of the TrialOne suite via integration to our flagship EDC product, TrialMaster®, using OmniConnect™, our enhanced web services API, and an integrated pharmacy module is planned for release later this year.

"TrialOne is the only available product that handles all aspects of the Phase I process from subject recruitment and clinical workflow management to laboratory sample management," said OmniComm's CTO, Randy Smith. "Other EDC solutions used in later stage trials do not include a proactive data collection system, which is imperative for the very time sensitive data collection processes inherent to early stage clinical studies."

Source
OmniComm Systems, Inc.